Found 13 matching trials
The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation PHASE2 This is a single-center, single-arm, prospective study to assess the effica...
Show More Location
Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University
Learn More & Join Trial
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) PHASE1 The purpose of this study is to assess the safety and efficacy of pembroliz...
Show More Status
Active Not Recruiting
Location
Multiple Locations
Learn More & Join Trial
Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer PHASE3 Evaluation of the impact of metastasis-directed therapy in patients with ca...
Show More Location
University Hospitals Leuven
Learn More & Join Trial
PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) PHASE1 The purpose of this research study is to evaluate safety, pharmacokinetics,...
Show More Location
University of Chicago
Learn More & Join Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort) PHASE3 The purpose of this study is to evaluate the efficacy and safety (including...
Show More Status
Active Not Recruiting
Learn More & Join Trial
CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer PHASE2 This is a prospective, randomized, open-label, phase II multicenter clinica...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Study to Evaluate CCS1477 in Advanced Tumours PHASE1 A Phase 1/2a study to assess the safety, tolerability, PK and biological ac...
Show More Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer PHASE3 The purpose of this study is to evaluate the efficacy and safety (including...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study) PHASE3 The purpose of this study is to evaluate the efficacy and safety of olapari...
Show More Learn More & Join Trial
PROLONG (PRostateOLaparibONcombinationGcc) Study N/A The study will generate regionally relevant data to inform clinical practic...
Show More Location
Multiple Locations
Learn More & Join Trial